Elucidation of genome-wide understudied proteins targeted by PROTAC-induced degradation using interpretable machine learning
PLOS Computational Biology · 2023
DOI: 10.1371/journal.pcbi.1010974 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Computational Biology, 2023. Verfasst von Li Xie und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Computer Science, Hunter College, The City University of New York, New York City, New York, United States of America. Hauptthemen laut MEDLINE: Ubiquitin-Protein Ligases, Alzheimer Disease. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 89 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS, NIGMS NIH HHS, National Institute of General Medical Sciences.
Abstract (Originalsprache)
Proteolysis-targeting chimeras (PROTACs) are hetero-bifunctional molecules that induce the degradation of target proteins by recruiting an E3 ligase. PROTACs have the potential to inactivate disease-related genes that are considered undruggable by small molecules, making them a promising therapy for the treatment of incurable diseases. However, only a few hundred proteins have been experimentally tested for their amenability to PROTACs, and it remains unclear which other proteins in the entire human genome can be targeted by PROTACs. In this study, we have developed PrePROTAC, an interpretable machine learning model based on a transformer-based protein sequence descriptor and random forest classification. PrePROTAC predicts genome-wide targets that can be degraded by CRBN, one of the E3 ligases. In the benchmark studies, PrePROTAC achieved a ROC-AUC of 0.81, an average precision of 0.84, and over 40% sensitivity at a false positive rate of 0.05. When evaluated by an external test set which comprised proteins from different structural folds than those in the training set, the performance of PrePROTAC did not drop significantly, indicating its generalizability. Furthermore, we developed an embedding SHapley Additive exPlanations (eSHAP) method, which extends conventional SHAP analysis for original features to an embedding space through in silico mutagenesis. This method allowed us to identify key residues in the protein structure that play critical roles in PROTAC activity. The identified key residues were consistent with existing knowledge. Using PrePROTAC, we identified over 600 novel understudied proteins that are potentially degradable by CRBN and proposed PROTAC compounds for three novel drug targets associated with Alzheimer’s disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Computer Science, Hunter College, The City University of New York, New York City, New York, United States of America.
- Ph.D. Program in Computer Science, The Graduate Center, The City University of New York, New York City, New York, United States of America.
- Helen and Robert Appel Alzheimer's Disease Research Institute, Feil Family Brain & Mind Research Institute, Weill Cornell Medicine, Cornell University, New York City, New York, United States of America.
Förderung
- NIA NIH HHS
- NIGMS NIH HHS
- National Institute of General Medical Sciences
- National Institute on Aging
Zitieren
APA
Xie, L., & Xie, L. (2023). Elucidation of genome-wide understudied proteins targeted by PROTAC-induced degradation using interpretable machine learning. PLOS Computational Biology. https://doi.org/10.1371/journal.pcbi.1010974
Vancouver
Xie L, Xie L. Elucidation of genome-wide understudied proteins targeted by PROTAC-induced degradation using interpretable machine learning. PLOS Computational Biology. 2023. doi:10.1371/journal.pcbi.1010974
BibTeX
@article{Xie2023,
author = {Xie, Li and Xie, Lei},
title = {Elucidation of genome-wide understudied proteins targeted by PROTAC-induced degradation using interpretable machine learning},
journal = {PLOS Computational Biology},
year = {2023},
doi = {10.1371/journal.pcbi.1010974}
}
EUVIMED